In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.

NCT00788255 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Anesthesia

Interventions

DRUG: Final exogenous oxytocin concentration=22.5 μU/mL
DRUG: Final exogenous oxytocin concentration=30.1μU/mL
DRUG: Final exogenous oxytocin concentration=32.9μU/mL

Sponsor

Stanford University